Document is current
Any future updates will be listed below
-
Authors
Erady, Chaitanya
Boxall, Adam http://orcid.org/0000-0002-3677-3043
Puntambekar, Shraddha
Suhas Jagannathan, N. http://orcid.org/0000-0002-1857-8789
Chauhan, Ruchi
Chong, David
Meena, Narendra
Kulkarni, Apurv
Kasabe, Bhagyashri
Prathivadi Bhayankaram, Kethaki
Umrania, Yagnesh
Andreani, Adam
Nel, Jean
Wayland, Matthew T. http://orcid.org/0000-0002-8095-858X
Pina, Cristina
Lilley, Kathryn S. http://orcid.org/0000-0003-0594-6543
Prabakaran, Sudhakaran http://orcid.org/0000-0002-6527-1085
- License Information
-
More Information
Article History
Received: 6 July 2020
Accepted: 18 November 2020
First Online: 25 January 2021
Competing interests
: S.P. and R.C. are co-founders of NonExomics, LLC. All other authors declare that there are no competing interests. Cambridge Enterprise Limited, Indian Institute of Science Education and Research, and International Centre for Genetic Engineering and Biotechnology have filed patent applications related to the work described here. The title of the patent application is “TREATMENT OF CANCER ASSOCIATED WITH DYSREGULATED NOVEL OPEN READING FRAME PRODUCTS” and “TREATMENT OF CANCER ASSOCIATED WITH VARIANT NOVEL OPEN READING FRAMES”. The U.S. Provisional Applications were filed on December 16, 2020, USSN 63/126,309 and 63/126,371.
